Announcements Trials
Browse Landscape

Phase

Phase NA 14Phase 4 2Phase 2/3 2Phase 2 2Phase 1 1

Status

Terminated 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 1

Conditions

Breast Neoplasms 2768Carcinoma, Non-Small-Cell Lung 2267Prostatic Neoplasms 1427Colorectal Neoplasms 1295Neoplasms 1260Multiple Myeloma 1086Lung Neoplasms 1050Neoplasm Metastasis 995Leukemia, Myeloid, Acute 985Lymphoma 900Melanoma 864Pancreatic Neoplasms 819Ovarian Neoplasms 805Carcinoma, Hepatocellular 782Stomach Neoplasms 754Recurrence 753Leukemia 733Lymphoma, Non-Hodgkin 685Leukemia, Lymphocytic, Chronic, B-Cell 665Squamous Cell Carcinoma of Head and Neck 618Lymphoma, Large B-Cell, Diffuse 617Precursor Cell Lymphoblastic Leukemia-Lymphoma 605Head and Neck Neoplasms 599Brain Neoplasms 593Carcinoma, Renal Cell 587Glioblastoma 573Rectal Neoplasms 565Sarcoma 523Myelodysplastic Syndromes 522Lymphoma, Follicular 516

Interventions

Adalimumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Sarcoidosis × Clear all
NCT04758650 2026-06-01

MITRAS

Universitair Ziekenhuis Brussel

Phase 2 Terminated
29 enrolled
Lymphoid

Hodgkin Disease, Lymphoma, Non-Hodgkin, Neoplasms, Sarcoidosis, Carotid Stenosis

NCT00311246 2020-08-25

Trial of Adalimumab in Progressive Sarcoidosis

University of Chicago

Phase 2 Terminated
11 enrolled 8 charts

Sarcoidosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡